APA (7th ed.) Citation

Burge, R., Papadimitropoulos, M., Henneges, C., Garcia, E., & Romiti, R. (2017). PSY36 - Ixekizumab Treatment Leads to Early Resolution of Bothersome Symptoms Versus Ustekinumab. Value in Health, 20(9), A902. https://doi.org/10.1016/j.jval.2017.08.2707

Chicago Style (17th ed.) Citation

Burge, RT, M. Papadimitropoulos, C. Henneges, EG Garcia, and R. Romiti. "PSY36 - Ixekizumab Treatment Leads to Early Resolution of Bothersome Symptoms Versus Ustekinumab." Value in Health 20, no. 9 (2017): A902. https://doi.org/10.1016/j.jval.2017.08.2707.

MLA (9th ed.) Citation

Burge, RT, et al. "PSY36 - Ixekizumab Treatment Leads to Early Resolution of Bothersome Symptoms Versus Ustekinumab." Value in Health, vol. 20, no. 9, 2017, p. A902, https://doi.org/10.1016/j.jval.2017.08.2707.